Withdrawal date: 2020-04-15
Telaprevir (Vx-950)
750 mg Tablett
| Previous product name: | |
| On the market: | Nej |
| Strength numeric with unit: | |
| ATC code: | J05AP02 |
| Product type: | Licensläkemedel |
| NPL id | 20130603021165 |
| Swedish approval number: | |
| Marketing authorisation number: | |
| Approval date: | |
| Authorisation procedure: | Ospecificerad |
| OriginID license: | |
| Approval country license: |
| Dose dispensing: | Nej |
| Dose disp. shelf life: | |
| Contains lactose: | Ospecificerad |
| Contains latex: | Ospecificerad |
| Controlled medicinal product: | Nej |
| Biological medicinal product: | |
| Narcotic class: | Ej narkotikaklassad |
| Prescription drug: | Receptbelagt |
| Repeat prescription: | |
| Additional monitoring: | Nej |
| Dispensing restriction: |
Pharmaceutical product 1:
| Ingredient role | Substance | Quantity | Unit | Additional | CAS no. |
|---|---|---|---|---|---|
| Aktiv beståndsdel | telaprevir | Angiven mängd är den avsedda, med normal variation | 402957-28-2 |
Company:
| Innehavare av godkännande för försäljning: |
|---|
| MAH saknas. Janssen-Cilag (Sponsor), Janssen-Cilag, 920 Rt 202, Raritan, NJ 08869, USA |